1. Home
  2. MCRB vs HUHU Comparison

MCRB vs HUHU Comparison

Compare MCRB & HUHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • HUHU
  • Stock Information
  • Founded
  • MCRB 2010
  • HUHU 2015
  • Country
  • MCRB United States
  • HUHU China
  • Employees
  • MCRB N/A
  • HUHU N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • HUHU
  • Sector
  • MCRB Health Care
  • HUHU
  • Exchange
  • MCRB Nasdaq
  • HUHU NYSE
  • Market Cap
  • MCRB 103.7M
  • HUHU 106.3M
  • IPO Year
  • MCRB 2015
  • HUHU 2024
  • Fundamental
  • Price
  • MCRB $12.09
  • HUHU $7.35
  • Analyst Decision
  • MCRB Hold
  • HUHU
  • Analyst Count
  • MCRB 4
  • HUHU 0
  • Target Price
  • MCRB $73.67
  • HUHU N/A
  • AVG Volume (30 Days)
  • MCRB 109.0K
  • HUHU 49.9K
  • Earning Date
  • MCRB 08-12-2025
  • HUHU 02-22-2025
  • Dividend Yield
  • MCRB N/A
  • HUHU N/A
  • EPS Growth
  • MCRB N/A
  • HUHU N/A
  • EPS
  • MCRB 8.98
  • HUHU N/A
  • Revenue
  • MCRB N/A
  • HUHU $18,149,244.00
  • Revenue This Year
  • MCRB N/A
  • HUHU N/A
  • Revenue Next Year
  • MCRB N/A
  • HUHU N/A
  • P/E Ratio
  • MCRB $1.50
  • HUHU N/A
  • Revenue Growth
  • MCRB N/A
  • HUHU 8.47
  • 52 Week Low
  • MCRB $6.53
  • HUHU $2.95
  • 52 Week High
  • MCRB $30.60
  • HUHU $9.89
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 66.74
  • HUHU N/A
  • Support Level
  • MCRB $10.67
  • HUHU N/A
  • Resistance Level
  • MCRB $12.84
  • HUHU N/A
  • Average True Range (ATR)
  • MCRB 1.09
  • HUHU 0.00
  • MACD
  • MCRB 0.34
  • HUHU 0.00
  • Stochastic Oscillator
  • MCRB 85.98
  • HUHU 0.00

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About HUHU HUHUTECH INTL GROUP INC

HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.

Share on Social Networks: